Haiti - FLASH : Inauguration of a Level 3 Biosafety Laboratory

iciHaiti - Football : FIFA / CONCACAF seminar on the license of D1 clubs

iciHaiti - Humanitarian : Supply of essential supplies increasingly difficult

iciHaiti - Special D1 Championship : Complete results of the first 9 days

iciHaiti - Florida : Interception of a luxury yacht filled with Haitian migrants

iciHaiti - USA : An AC-130 military plane lands in Port-au-Prince

more news

Haiti - News : Zapping...

Haiti - Education : 44 million to «offer young Haitians a better future

Haiti - FLASH : Cases of suicidal tendencies becoming more and more frequent

Haiti - FLASH : Ron DeSantis announces the successful evacuation of 722 Americans from Haiti

Haiti - FLASH : 312,000 Haitian refugees and asylum seekers around the world

more news

Haiti - FLASH : Inauguration of a Level 3 Biosafety Laboratory
23/12/2017 08:21:02

Thursday, the Ministry of Public Health and Population’s National Public Health Laboratory (LNSP) inaugurated a national biosafety level 3 (BSL-3) laboratory. The U.S. Government through the U.S. Centers for Disease Control and international and local partners supported the establishment of this laboratory which will be used for tuberculosis (TB) and multidrug resistant tuberculosis (MDR-TB) diagnosis and treatment. In addition to increasing Haiti’s capacity to diagnose and treat cases of TB and MDR-TB, the lab will allow the country to monitor the evolution of TB drug resistance in Haiti and to handle emerging infectious agents that pose a significant risk to laboratory staff and the environment.

Acting Deputy Chief of Mission Robert Hannan attended the ceremony noting the critical role laboratory services play in diagnosing, treating, and responding to potential disease threats. "With the opening of the BSL-3 laboratory, Haiti is taking another crucial step toward health security. The Ministry will be able to carry out TB culture, allowing for critical diagnoses; and to conduct the vital research necessary to help better understand and control drug resistance in Haiti."

Dr. Lauré Adrien, Director General of the Ministry of Public Health and Population, thanked the U.S. Government for their support in establishing the laboratory and noted that a health system cannot exist without a strong laboratory system.

The Director of the National Public Health Laboratory Dr. Jacques Boncy was honored to commemorate the opening of the lab, stating: "We would like to thank the U.S. Government through CDC for their technical and financial assistance. Now let's use this technology to understand the diversity of mycobacterium tuberculosis strains circulating in the country and region, including the transmission of multidrug-resistant tuberculosis."

The director of Haiti’s National Tuberculosis Control Program (PNLT), Dr. Willy Morose, said "the operationalization of the national BSL-3 laboratory is a comfort to PNLT. Its implementation is good news for providers of the 257 sites for the treatment of tuberculosis for better bacteriological monitoring of cases of tuberculosis".

With 188 cases per 100,000 inhabitants, Haiti has the highest incidence of TB in the Western Hemisphere. During the 2010 earthquake response, CDC supported intensified disease surveillance, which helped improve diagnosis and treatment of TB cases. The opening of the national BSL-3 laboratory reaffirms Haiti’s commitment to controlling the spread of TB and MDR-TB and addressing infectious disease threats.

Learn more about Biosafety Level 3 Containment Laboratories :
A biosafety containment laboratory 3 is a vacuum room with double HEPA filtration to treat the air evacuated from the laboratory, equipped with an airlock, autoclave double entry, a strictly controlled access, requires at work the protection of the respiratory tract and mucous membranes, personnel trained in biosecurity procedures, and ongoing medical surveillance.

This type of laboratory concerns inter alia the study and analysis :

Class 3 non-genetically modified microorganisms (with significant human pathogenicity but low risk for the community and for which prophylaxis or effective treatments are known).
Class 3 genetically modified microorganisms in which the cloned vectors or sequences do not increase the risk class.
Genetically modified non-pathogenic or class 2 microorganisms carrying either genes encoding proteins with significant pathogenicity to humans or large fragments of genomes of class 3 microorganisms.
Animal cells harboring vectors that contain genes encoding proteins with pathogenic potential for humans or large fragments of genomes of class 3 or Ea3 microorganisms.
Plant cells and transgenic plants producing Ep3 class viruses.

HL/ HaitiLibre